Zoll announces several management changes

371

Zoll Medical has announced a series of management changes within the company. The company’s current chief executive officer, Richard A Packer, will take a new position leading Asahi Kasei’s global Healthcare Business Unit. Asahi Kasei acquired Zoll in 2012.

In Packer’s new role as a primary executive officer of Asahi Kasei Corporation, he will help build the healthcare businesses into a third pillar of the Asahi Kasei Group. The Healthcare Business Unit will consist of Asahi Kasei Pharma, Asahi Kasei Medical, Zoll, and future global health care companies. Packer will also serve as the non-executive chairman of Zoll.

Packer joined Zoll in 1992, and was appointed president in 1995. He was appointed chief executive officer in 1999. Packer holds an MBA from the Harvard Business School, as well as engineering degrees from Rensselaer Polytechnic Institute.

Jonathon A Rennert-currently president of Zoll’s resuscitation business-will take over as chief executive officer of Zoll.

Since joining Zoll in 2008 as president, Rennert has led the global growth of the company, has diversified the product portfolio through the addition of transport ventilators and intrathoracic pressure regulation (IPR) therapy, and has overseen the establishment of Asahi Kasei Zoll Medical, Zoll’s Japanese subsidiary.

Prior to joining Zoll, Rennert led the analytical instruments business at PerkinElmer, and earlier in his career held manufacturing and engineering leadership positions with United Technologies and General Electric. Rennert holds master’s degrees in management and mechanical engineering from the Massachusetts Institute of Technology (Cambridge, USA) and a bachelor’s degree in mechanical and aerospace engineering from Princeton University (Princeton, USA).

A Ernest Whiton, now senior vice president of International Operations, will replace Rennert as president of Zoll’s resuscitation business.

During the three years Whiton has served as senior vice president of International Operations, Zoll’s international resuscitation business has increased by over 50%. During the previous 15 years between 1998 and 2013, he served as chief financial officer and vice president of Administration, helping to shaping the company’s mission and strategy. According to a company release, this led to significant company growth in revenue while Zoll was listed on the US National Association of Securities Dealers Automated Quotations, prior to Zoll’s acquisition by Asahi Kasei in April 2012.

Prior to joining Zoll, Whiton was vice president and chief accounting officer of Ionics, a global separations technology company, which he joined in 1993. Earlier, he was a manager at Price Waterhouse. Whiton holds an MBA from the Harvard Business School (Boston, USA) and a bachelor’s degree in accounting from Bentley College (Waltham, USA).

(Visited 55 times, 1 visits today)